SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-025064
Filing Date
2021-02-18
Accepted
2021-02-18 09:26:39
Documents
6
Period of Report
2021-02-18

Document Format Files

Seq Description Document Type Size
1 6-K tm217153d1_6k.htm 6-K 17199
2 EXHIBIT 1.1 tm217153d1_ex1-1.htm EX-1.1 213500
3 EXHIBIT 5.1 tm217153d1_ex5-1.htm EX-5.1 11202
4 EXHIBIT 99.1 tm217153d1_ex99-1.htm EX-99.1 13143
5 GRAPHIC image_005.jpg GRAPHIC 10495
6 GRAPHIC image_007.jpg GRAPHIC 2096
  Complete submission text file 0001104659-21-025064.txt   273659
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36345 | Film No.: 21647842
SIC: 2834 Pharmaceutical Preparations